LAVA Therapeutics NV (LVTX) — Financial Flexibility Index
LAVA Therapeutics NV (LVTX) has a Financial Flexibility Index of -0.12x as of September 2025. Free cash flow of $-4.87 Million (operating CF $-4.87 Million minus capex $0.00) represents 0% of total liabilities ($39.23 Million). Check LVTX PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
LAVA Therapeutics NV Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for LAVA Therapeutics NV across 6 annual periods. See working capital position of LAVA Therapeutics NV to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for LAVA Therapeutics NV (2019–2024)
Year-by-year free cash flow to debt coverage for LAVA Therapeutics NV. For the full company profile including market capitalisation, see LVTX stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.37x | $-19.52 Million | $-19.54 Million | $53.09 Million | ▲ +53.0% |
| 2023 | -0.78x | $-39.55 Million | $-40.28 Million | $50.53 Million | ▼ -1070.1% |
| 2022 | 0.08x | $4.63 Million | $4.04 Million | $57.38 Million | ▲ +106.0% |
| 2021 | -1.34x | $-27.88 Million | $-28.65 Million | $20.88 Million | ▼ -95.1% |
| 2020 | -0.68x | $-8.80 Million | $-9.31 Million | $12.87 Million | ▲ +74.3% |
| 2019 | -2.66x | $-7.85 Million | $-8.62 Million | $2.95 Million | — |